Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · IEX Real-Time Price · USD
3.700
-0.250 (-6.33%)
At close: Jul 19, 2024, 4:00 PM
3.840
+0.140 (3.78%)
Pre-market: Jul 22, 2024, 8:07 AM EDT
Zentalis Pharmaceuticals Employees
Zentalis Pharmaceuticals had 124 employees as of December 31, 2023. The number of employees decreased by 32 or -20.51% compared to the previous year.
Employees
124
Change (1Y)
-32
Growth (1Y)
-20.51%
Revenue / Employee
$327,097
Profits / Employee
-$1,765,806
Market Cap
262.75M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 124 | -32 | -20.51% |
Dec 31, 2022 | 156 | -21 | -11.86% |
Dec 31, 2021 | 177 | 53 | 42.74% |
Dec 31, 2020 | 124 | 62 | 100.00% |
Dec 31, 2019 | 62 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Auna SA | 14,958 |
MultiPlan | 2,800 |
Viemed Healthcare | 996 |
LifeMD | 211 |
Tenaya Therapeutics | 140 |
Nektar Therapeutics | 137 |
Monte Rosa Therapeutics | 133 |
Inovio Pharmaceuticals | 122 |
ZNTL News
- 7 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zentalis Pharmaceuticals, Inc. - ZNTL - Accesswire
- 20 days ago - Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Investigation Into Zentalis Pharmaceuticals, Inc. (ZNTL) Announced byHolzer & Holzer, LLC - GlobeNewsWire
- 4 weeks ago - Why Is Small-Cap Cancer-Focused Zentalis Pharma Stock Trading Lower On Tuesday? - Benzinga
- 4 weeks ago - US FDA puts partial clinical hold on Zentalis' cancer drug studies; shares drop - Reuters
- 4 weeks ago - Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program - GlobeNewsWire
- 7 weeks ago - Zentalis Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, M.D., to Board of Directors - GlobeNewsWire